S1.3 - Targeted therapy in radioiodine refractory thyroid cancer
Radioiodine-refractory thyroid cancer (RAIR-TC) represents a challenging subset of differentiated thyroid cancers characterized by loss of iodine avidity and poor or absent response to conventional radioactive iodine therapy. Over the past decade, advances in molecular biology have significantly improved the understa...